325 related articles for article (PubMed ID: 32920285)
1. Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms.
Haddadi R; Shahidi Z; Eyvari-Brooshghalan S
Phytomedicine; 2020 Dec; 79():153320. PubMed ID: 32920285
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action.
Borah A; Paul R; Choudhury S; Choudhury A; Bhuyan B; Das Talukdar A; Dutta Choudhury M; Mohanakumar KP
CNS Neurosci Ther; 2013 Nov; 19(11):847-53. PubMed ID: 24118806
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
5. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine.
Jin S; Zhang L; Wang L
Biomed Pharmacother; 2023 Sep; 165():115215. PubMed ID: 37494786
[TBL] [Abstract][Full Text] [Related]
6. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
[TBL] [Abstract][Full Text] [Related]
7. New therapeutic potentials of milk thistle (Silybum marianum).
Milić N; Milosević N; Suvajdzić L; Zarkov M; Abenavoli L
Nat Prod Commun; 2013 Dec; 8(12):1801-10. PubMed ID: 24555302
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic strategy for Parkinson's and Alzheimer's disease.
Esposito E; Cuzzocrea S
Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
[TBL] [Abstract][Full Text] [Related]
9. A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin.
Devi KP; Malar DS; Braidy N; Nabavi SM; Nabavi SF
Curr Drug Targets; 2017; 18(13):1529-1536. PubMed ID: 28025940
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (Review).
Vaid M; Katiyar SK
Int J Oncol; 2010 May; 36(5):1053-60. PubMed ID: 20372777
[TBL] [Abstract][Full Text] [Related]
11. Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.
de Andrade Teles RB; Diniz TC; Costa Pinto TC; de Oliveira Júnior RG; Gama E Silva M; de Lavor ÉM; Fernandes AWC; de Oliveira AP; de Almeida Ribeiro FPR; da Silva AAM; Cavalcante TCF; Quintans Júnior LJ; da Silva Almeida JRG
Oxid Med Cell Longev; 2018; 2018():7043213. PubMed ID: 29861833
[TBL] [Abstract][Full Text] [Related]
12. Phytochemical analysis, molecular docking and antiamnesic effects of methanolic extract of Silybum marianum (L.) Gaertn seeds in scopolamine induced memory impairment in mice.
Nazir N; Karim N; Abdel-Halim H; Khan I; Wadood SF; Nisar M
J Ethnopharmacol; 2018 Jan; 210():198-208. PubMed ID: 28842342
[TBL] [Abstract][Full Text] [Related]
13. Effects of Silymarin on Diabetes Mellitus Complications: A Review.
Stolf AM; Cardoso CC; Acco A
Phytother Res; 2017 Mar; 31(3):366-374. PubMed ID: 28124457
[TBL] [Abstract][Full Text] [Related]
14. Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review.
Tajmohammadi A; Razavi BM; Hosseinzadeh H
Phytother Res; 2018 Oct; 32(10):1933-1949. PubMed ID: 30015401
[TBL] [Abstract][Full Text] [Related]
15. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
Lee Y; Park HR; Chun HJ; Lee J
J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
[TBL] [Abstract][Full Text] [Related]
16. Silibinin: a novel inhibitor of Aβ aggregation.
Yin F; Liu J; Ji X; Wang Y; Zidichouski J; Zhang J
Neurochem Int; 2011 Feb; 58(3):399-403. PubMed ID: 21185897
[TBL] [Abstract][Full Text] [Related]
17. Combination of Zizyphus jujuba and silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats.
Gupta S; Gupta YK
J Ethnopharmacol; 2017 Feb; 197():118-127. PubMed ID: 27452658
[TBL] [Abstract][Full Text] [Related]
18. Silymarin protects neurons from oxidative stress associated damages in focal cerebral ischemia: a behavioral, biochemical and immunohistological study in Wistar rats.
Raza SS; Khan MM; Ashafaq M; Ahmad A; Khuwaja G; Khan A; Siddiqui MS; Safhi MM; Islam F
J Neurol Sci; 2011 Oct; 309(1-2):45-54. PubMed ID: 21840019
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease.
Mei M; Zhou Y; Liu M; Zhao F; Wang C; Ding J; Lu M; Hu G
Neuropharmacology; 2019 Dec; 160():107758. PubMed ID: 31494143
[TBL] [Abstract][Full Text] [Related]
20. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.
Mastron JK; Siveen KS; Sethi G; Bishayee A
Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
